Zobrazeno 1 - 10
of 1 134
pro vyhledávání: '"F Lordick"'
Autor:
M. Alsina, A.E. Huerta, F. Lordick, S. Verschueren, M. Moehler, E. Fontana, E. Smyth, F. Sclafani, A.D. Wagner, L. Rimassa, A. Lamarca, C. Neuzillet, R. Obermannová
Publikováno v:
ESMO Gastrointestinal Oncology, Vol 5, Iss , Pp 100074- (2024)
Background: Precision oncology is gaining momentum in managing patients with gastrointestinal cancers. This study examines the implementation of personalized medicine technologies in upper gastrointestinal (UGI) oncology across European academic cent
Externí odkaz:
https://doaj.org/article/468cbae5db3841f4987a48225e5bfaba
Autor:
R. Veelken, S. Ebel, A. Schindler, F. Lordick, M.F. Struck, C. Girbardt, F. Ziemssen, D. Seehofer, T. Denecke, T. Berg, F. van Bömmel
Publikováno v:
ESMO Gastrointestinal Oncology, Vol 5, Iss , Pp 100082- (2024)
Background: Hepatic chemosaturation by isolated percutaneous liver perfusion (CS-PHP) with melphalan controls hepatic tumor growth. However, optimal treatment frequency and the prognostic relevance of extrahepatic tumor manifestation remain unclear.
Externí odkaz:
https://doaj.org/article/bf47370392274d338b851d336870db60
Autor:
C.A. Cella, D. Ciardiello, L. Gervaso, H. van Laarhoven, L. Nezi, C. Catozzi, F. Lordick, E. Smyth, S. de Pascale, L. Benini, C. Valenza, L. Guidi, U. Fumagalli Romario, N. Fazio
Publikováno v:
ESMO Gastrointestinal Oncology, Vol 4, Iss , Pp 100048- (2024)
For decades, the stomach was considered a sterile organ, due to the acid environment. However, starting from the discovery of Helicobacter pylori, this concept has progressively refined. By damaging the hydrochloric acid-secreting glands, H. pylori i
Externí odkaz:
https://doaj.org/article/55d88948b5904457a748afe3001c26df
Autor:
B. Kobitzsch, G. Stocker, U.T. Hacker, S. Junge, C. Pauligk, S.-E. Al-Batran, T.O. Goetze, F. Lordick
Publikováno v:
ESMO Gastrointestinal Oncology, Vol 4, Iss , Pp 100051- (2024)
Background: Treatment of metastatic and locally advanced unresectable esophagogastric adenocarcinoma (EGA) after first-line therapy has limited efficacy. Sacituzumab govitecan (SG) is an antibody-drug conjugate (ADC) linking a TROP-2-directed antibod
Externí odkaz:
https://doaj.org/article/2bcb77ac3c234773a4a37199de441208
Publikováno v:
ESMO Gastrointestinal Oncology, Vol 1, Iss , Pp 27-39 (2023)
Immune checkpoint inhibition (ICI) has revolutionized cancer therapy, including treatment of hepatocellular carcinoma (HCC) which comprises 80%-90% of all liver cancers, the third most common cause of cancer-related death worldwide. The main targeted
Externí odkaz:
https://doaj.org/article/ec54ec023eef401ea6b50da45fed6f7c
Autor:
I. Ben-Aharon, F. Lordick
Publikováno v:
ESMO Gastrointestinal Oncology, Vol 1, Iss , Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/8987bf7cf81b4007834fdbfddff91f3f
Publikováno v:
Immuno-Oncology and Technology, Vol 9, Iss , Pp 100027- (2021)
Externí odkaz:
https://doaj.org/article/ce466b36c552465dafcbe0d4fd8004d5
Autor:
B. Jansen-Winkeln, J. Eberth, Y. Moulla, M. Mehdorn, S. Niebisch, K. Schierle, H. Bläker, F. Lordick, I. Gockel, R. Thieme
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 149:1331-1341
Purpose Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new, palliative approach for patients with peritoneal surface malignancies (PSMs). Its main goals are to control symptoms and ascites. For this experimental procedure, treatment ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e167ffad0672ac23c5f61c0bf1d4361
https://doi.org/10.1007/s00432-022-04517-w
https://doi.org/10.1007/s00432-022-04517-w
Autor:
F. Lordick, F. Carneiro, S. Cascinu, T. Fleitas, K. Haustermans, G. Piessen, A. Vogel, E.C. Smyth
Publikováno v:
Annals of Oncology. 33:1005-1020
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a43b061751501793bad24fb85689a63c
https://doi.org/10.1016/j.annonc.2022.07.004
https://doi.org/10.1016/j.annonc.2022.07.004
Autor:
H. C. Chung, Y-J. Bang, J. M. Xu, F. Lordick, A. Sawaki, O. Lipatov, M. Lehle, М. Pickl, J. Ruschoff, E. Van Cutsem
Publikováno v:
Креативная хирургия и онкология, Vol 0, Iss 4, Pp 16-22 (2017)
In this article results of the multicenter trial are displayed. Data of successful efficacy of trastuzumab treatment in HER2 positive gastric cancer patients has shown.
Externí odkaz:
https://doaj.org/article/d5aeddf98eff412786d5d21ee507bca1